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Mutations in endoglin, a TGFβ/BMP coreceptor, are causal for hereditary hemorrhagic telangiectasia
(HHT). Endoglin-null (Eng-/-) mouse embryos die at embryonic day (E)10.5–11.5 due to defects in an-
giogenesis. In part, this is due to an absence of vascular smooth muscle cell differentiation and vessel
investment. Prior studies from our lab and others have shown the importance of endoglin expression in
embryonic development in both endothelial cells and neural crest stem cells. These studies support the
hypothesis that endoglin may play cell-autonomous roles in endothelial and vascular smooth muscle cell
precursors. However, the requirement for endoglin in vascular cell precursors remains poorly deﬁned.
Our objective was to speciﬁcally delete endoglin in neural crest- and somite-derived Pax3-positive
vascular precursors to understand the impact on somite progenitor cell contribution to embryonic
vascular development. Pax3Cre mice were crossed with Engþ/ mice to obtain compound mutant
Pax3Cre/þ;Engþ/ mice. These mice were then crossed with homozygous endoglin LoxP-mutated
(EngLoxP/LoxP) mice to conditionally delete the endoglin gene in speciﬁc lineages that contribute to en-
dothelial and smooth muscle constituents of developing embryonic vessels. Pax3Cre/þ;EngLoxP/ mice
showed a variety of vascular defects at E10.5, and none of these mice survived past E12.5. Embryos
analyzed at E10.5 showed malformations suggestive of misdirection of the intersomitic vessels. The
dorsal aorta showed signiﬁcant dilation with associated vascular smooth muscle cells exhibiting dis-
organization and enhanced expression of smooth muscle differentiation proteins, including smooth
muscle actin. These results demonstrate a requirement for endoglin in descendants of Pax3-expressing
vascular cell precursors, and thus provides new insight into the cellular basis underlying adult vascular
diseases such as HHT.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
The transforming growth factor beta (TGFβ) and bone mor-
phogenetic protein (BMP) receptor pathways play critical but still
incompletely understood roles in cardiovascular development, and
represent key regulatory systems that govern normal vascular
remodeling, the vascular response to injury, reperfusion following
ischemic revascularization, and vessel maturation (David et al.,
2008; Ricard et al., 2012). Autosomal dominant mutations in the
TGFβ/BMP co-receptor endoglin (ENG) (McAllister et al., 1994), orsearch Institute, 81 Research
07 396 8179.the type-I receptor, activin-like kinase-1 (ACVRL1; also known as
ALK1) (Johnson et al., 1996), cause the hereditary vascular diseases
hereditary hemorrhagic telangiectasia (HHT) types 1 and 2 (HHT1,
HHT2), respectively. These related disorders affect between 1 in
5000 to 8000 people in the US, though this may be an under-
estimate (Easey et al., 2003). HHT patients present with symptoms
that include debilitating nose bleeds (epistaxis) (Sabba et al., 2007)
that negatively impact their quality of life (Pasculli et al., 2004),
and brain, lung, liver and intestinal arteriovenous malformations
(AVM), which can result in mortality (Giordano et al., 2006;
Kjeldsen et al., 2000). In HHT, the maturation phase of angiogen-
esis appears to be affected, as mice with endoglin- or Alk1-deﬁ-
cient vessels, and human telangiectases, show loss of integrity,
signs of defective pericyte investment (Bailly et al., 2010; Braver-
man et al., 1990; Lebrin et al., 2010), and altered levels of vessel-
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et al., 2004). A more complete understanding of the functions of
endoglin during the processes of vascular development and vessel
homeostasis is critical to developing improved therapies for HHT.
Endoglin null (Eng-/-) embryos die at embryonic day (E) 10.5–
11.5 due to defects in cardiac morphogenesis and angiogenesis
due, in part, to an absence of differentiated vascular smooth
muscle cells (Arthur et al., 2000; Bourdeau et al., 1999; Li et al.,
1999). We have previously shown that endoglin is required in non-
endothelial neural crest stem cells for maintenance of myogenic
potential (Mancini et al., 2007). Moreover, in endoglin null em-
bryos, conditional expression of an endoglin transgene in either
endothelial or smooth muscle cells partially rescues smooth
muscle cell differentiation and investment of the developing
E9.5E10.5 dorsal aorta (Mancini et al., 2009). Thus, endoglin's
functions during angiogenesis are complex, likely comprising both
cell-autonomous (e.g., adhesive, TGFβ/BMP signaling), autocrine,
and paracrine (e.g., regulation of chemokine and matrikine ex-
pression (Young et al., 2012, 2015)) signaling roles in multiple cell
types that contribute to embryonic blood vessel development.
However, the requirement for endoglin expression in vascular cell
precursors for vessel formation remains unclear.
Vascular smooth muscle cells originate from multiple cell types
during embryogenesis, including cells migrating from the neural
crest and the lateral plate mesoderm (Majesky, 2007). Dermo-
myotome cells of the somite, marked by Pax3 expression, give rise
not only to smooth muscle cells of the dorsal aorta (Esner et al.,
2006), but also to a subpopulation of endothelial cells in the aortic
endothelium (Esner et al., 2006; Stoller et al., 2008) and inter-
somitic vessels (Mayeuf-Louchart et al., 2014). Therefore, to assess
the cell-autonomous requirement of endoglin for the contribution
of Pax3-positive vascular cell precursors to the embryonic dorsal
aorta and intersomitic vessels, we examined the consequences of
conditional deletion of endoglin in Pax3-derived cells.2. Materials and methods
2.1. Mice
The Engtm1Hma strain has a targeted mutation in the endoglin
(Eng) gene (MGI:2177822) (Allinson et al., 2007; Arthur et al.,
2000) and the Engtm2.1Hma strain has loxP sites ﬂanking exons 5-6,
generating a conditional allele activated by Cre recombinase
(MGI:3712802) (Allinson et al., 2007; Arthur et al., 2000). Both Eng
alleles were obtained from Helen Arthur (Institute of Genetic
Medicine, Newcastle University, Newcastle upon Tyne, UK.). The Tg
(Wnt1-cre)11Rth strain (MGI:2386570, (Danielian et al., 1998)) and
the Pax3tm1(cre)Joe (MGI:3573783, (Lang et al., 2005)) were obtained
from the Jackson Laboratory (Bar Harbor, ME). The
Gt(ROSA)26Sortm1Sor strain contains a Cre-inducible lacZ gene, and
was obtained from Jackson Laboratory (Soriano, 1999). All mice
were maintained in the C57BL/6 background. Noon of the day of
vaginal plug observation was designated E0.5. Breeding, main-
tenance, and experimentation were conducted according to the
NIH standards established in the Guidelines for the Care and Use
of Experimental Animals. All studies were approved by the Maine
Medical Center Institutional Animal Care and Use and Institutional
Biosafety Committees.
2.2. PCR genotyping
Primers used for polymerase chain reaction genotyping of
parental mice and embryonic tissue were: Eng Flox, CCATTCT-
CATCCTGCATGGTCC and CCACGCCTTTGACCTTGCTTCC; Engþ/
allele beta galactosidase (LacZ), GTCGTTTTACAACGTCGTGACT andGATGGGCGCATCGTAACCGTGC; Engþ/ null allele, GAGCTCGGT-
CAGAGGTCAAAG and CTGGGACGTCGTATGGGTAG; Eng Flox re-
combination, GGTCAGCCAGTCTAGCCAAG and CCACGCCTTTGTCCT
TGC; Cre allele, GCTGGTTAGCACCGCAGGTGTAGAG and CGCCATCT
TGCAGCAGGCGCACC.
2.3. Analysis of mouse tissues
All mice and embryos were genotyped twice: after birth and
following euthanasia, as described (Mancini et al., 2009; Romero
et al., 2011). Mice were anesthetized with avertin, and embryos
were whole mount stained for beta-galactosidase activity, pro-
cessed for parafﬁn embedding, and sectioned, harvested, ﬁxed,
and stained for beta galactosidase with eosin counterstaining as
described previously (Mancini et al., 2009).
2.4. Histology, Immunohistochemistry, and Intracardiac Ink
Injections
Antibodies used for immunoﬂuorescence and im-
munohistochemistry were: α-SMA-CY3 conjugated (Sigma), α-CD34
(Pharmingen). The slides were examined with a Zeiss Axioskop
microscope (Thornwood, NY, USA). Imaging and color histogram
analysis were performed using Image J software. Histological ana-
lysis, immunohistochemistry for PECAM-1 (CD31; BD Pharmingen)
and intracardiac India ink injections were performed as described
previously (Krebs et al., 2004, 2000). Aortic sectional areas were
measured on serial images using the FIJI version of ImageJ. Sig-
niﬁcance of area differences was determined using Student's T test
on three measurements on three separate cells per stack element.
2.5. Confocal Microscopy
Control and mutated Pax3Cre/þ;EngLoxP/ mouse embryos at
E10.5 were formalin ﬁxed, then clariﬁed by stepwise immersion in
glycerol at 25%, 50%, 75%, 90% and 100% v./v. Embryos were
counterstained with mouse isolectin IB4 (Abcam) and rabbit an-
tibody to PDGFRβ (AbCam), followed by Alexa 488 conjugated
anti-mouse IgG antibodies and Alexa 546 anti-rabbit IgG anti-
bodies. Immunoﬂuorescently stained embryos were studied using
a Leica SP8 confocal microscope with 10 objective. The stacks of
optical sections covering the full depth of laterally positioned
embryos were collected and 3D reconstruction was achieved using
the IMARIS program.
2.6. RNA extraction and real time quantitative RT-PCR analysis
RNA isolation and real-time quantitative RT-PCR (qRT-PCR)
analyses were carried out essentially as described (Young et al.,
2012). For these experiments, E10.5 embryos were washed in PBS.
Embryos were cut just below the forelimbs and above the hin-
dlimbs, and the resulting thoracic segment was used for total RNA
isolation using RNeasy plus (Qiagen). qRT-PCR reactions were run
in triplicate on a BioRad iQ5 system. Primers used for quantitative
RT-PCR of mouse embryo cDNAs are listed below:
Endoglin, AGCCCCACAAGTCTTGCAG and GCTAGTGGTA-
TATGTCACCTCGC; Smooth muscle alpha actin, AAATCAGA-
CATGTGCTACCC and TCAAATACC CCGTTTACATC; Smooth muscle
myosin heavy chain (SMMHC1), AGAGCAAACTCAGGAGAGGA and
TCACTGGCTTTGGTTCCATT; SM22alpha, CCTTTAAACCCCTCACCCAG
and CGTAGGATGGACCCTTGTTG; Smooth muscle calponin1
(CNN1), GCATGA- CAGTGTTGGGCTT and CTCACTCAGCTCTGGG-
TACT. Normalization primers for qRT-PCR analysis were: Mouse
β2-microglobulin, CTGACCGGCCTGTATGCTAT and CCGTTCTTCAG-
CATTTGGAT. Statistical signiﬁcance is presented as the p value,
with signiﬁcance set to p¼0.05 or less.
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We previously found that transgenic expression of endoglin in
endothelial and SM22-alpha-positive Eng-/- mesodermal cells
produced signiﬁcant cell-autonomous effects on vascular smooth
muscle cell differentiation in vivo (Mancini et al., 2009). Therefore,
to investigate endoglin loss-of-function in neural crest-derived
vascular smooth muscle cell precursors, we combined a condi-
tional endoglin null allele (EngLoxP/LoxP (Allinson et al., 2007)) with
Pax3Cre (Li et al., 2000). Unlike Wnt1Cre (Brault et al., 2001), Pax3
is expressed in paraxial mesoderm and somite derivatives (Eng-
leka et al., 2005; Mansouri et al., 2001; Schubert et al., 2001) that
previous work suggests (Esner et al., 2006) contributes to the
vascular precursor cells forming the dorsal aorta. Therefore, en-
doglin excision was driven by Pax3Cre to determine whether its
expression is required for vascular precursor cell contributions to
endothelial and vascular smooth muscle cells comprising the
mouse vasculature.
3.1. Pax3Cre-mediated deletion of endoglin is embryonic lethal
The conditional endoglin null allele (EngLoxP/LoxP) used here
possesses LoxP sites that ﬂank exons 5 and 6, permitting the
creation of a null allele following recombination with Cre re-
combinase. To sensitize recombination at the endoglin locus, we
ﬁrst crossed Pax3Cre transgenic mice with Engþ/ mice (Li et al.,
2000; Liu et al., 2006). Next, the resulting Pax3Cre;Engþ/ mice
were crossed with homozygous EngLoxP/LoxP mice. No Pax3Cre;
EngLoxP/ mice were born alive (Table 1). The Wnt1Cre strain
(Brewer et al., 2004) was similarly used to target neural crest en-
doglin expression in mouse E10–11 embryos. However, no appar-
ent phenotype was observed Wnt1Cre; EngLoxP/ mice (Table 1)
and, therefore, this approach was not pursued further.
3.2. Pax3Cre;rosa embryo staining indicates expression in vascular
smooth muscle precursors and a subset of endothelial cells
We visualized the distribution of recombination of the Pax3Cre
and, for comparison, Wnt1Cre strains by examining the pattern of
beta-galactosidase expression in a LacZ Cre reporter line (Soriano,
1999). As has been reported previously (Stoller et al., 2008), beta-
galactosidase-positive (βgalþ) cells derived from Pax3Cre-ex-
pressing cells were seen at E9.5 and E10.5 in the dorsal neural
tube, throughout the neural crest, nearby mesenchyme, and to a
lesser extent in the myotome (Fig. 1A–F). Also as reported (Stoller
et al., 2008), we observed βgal-positive cells in the aorta (Fig. 1C),
and also in vessels in the head region (Fig. 1A) and in the cardinal
vein (Fig. 1D). βgal-positive cells were also found in someTable 1
Progeny fromWnt1Cre;Engþ / orPax3Cre;Engþ / crosses withEngLoxP/LoxP
mice.Wnt1Cre;Engþ/ were crossed with EngLoxP/LoxP mice and 10 litters (63 mice)
were analyzed. Pax3Cre;Engþ/ were crossed with EngLoxP/LoxP mice and 9 litters
(40 mice) were analyzed. If mice are viable, expected outcome is 25% of each of
4 genotypes.
Genotype Positive/Total (%)
Tg(Wnt1-Cre);EngLoxP/þ 21/63 (33.3%)
EngLoxP/þ 16/63 (25%)
EngLoxP/ 10/63 (15.9%)
Tg(Wnt1-Cre);EngLoxP/ 16/63 (25.4%)
Pax3Cre/þ;EngLoxP/þ 13/40 (32.5%)
EngLoxP/þ 16/40 (40%)
EngLoxP/ 11/40 (27.5%)
Pax3Cre/þ;EngLoxP/ a0/40 (0%)
a Pax3Cre/þ;EngLoxP/ vs. Tg(Wnt1-Cre);EngLoxP/ , P¼0.005.endothelial cells in the dorsal one third of the dorsal aorta at the
heart level (Fig. 1D), but not at the caudal level (Fig. 1F). Therefore,
detection of Pax3Cre activity in a subset of endothelial cells sug-
gests that loss of endoglin expression in Pax3-derived rare en-
dothelial cells can contribute to the Pax3Cre-mediated endoglin
deletion phenotype. A similar analysis of the Wnt1Cre expression
pattern showed strong βgal-positive cells in the dorsal neural tube
and neural crest, but little evidence of expression in the devel-
oping vasculature (Fig. 1G–I).
3.3. Conditional targeting Pax3-positive cells causes a vascular
phenotype
Pax3Cre;Engþ / mice were used to generate tissue-restricted
endoglin null (Pax3Cre;EngLoxP/) mice. We conﬁrmed Cre re-
combination of endoglin in embryos resulting from
Pax3Cre/þ;Engþ / x EngLoxP/LoxP homozygote crosses. Embryos
were positive for the EngLoxP allele (data not shown) and either or
both of the Cre and LacZ-targeted Eng null alleles (Engþ /LacZ) (Ar-
thur et al., 2000). Using published EngLoxP recombination-speciﬁc
PCR primers (Allinson et al., 2007), we observed full correlation
between the presence of the Pax3Cre allele and the Eng re-
combined allele in both head and trunk E9.5E10.5 embryo sec-
tions (Fig. 2A, lanes 1, 4–7, and 12). Recombination was not ob-
served in the embryonic yolk sac, consistent with a lack of Pax3-
positive cell contribution to this tissue. Pax3Cre;EngLoxP/ embryos
(lanes 4, 6, and 7) with presumptive abrogation of endoglin ex-
pression in Pax3-expressing cells presented as pale, with ex-
panded and hemorrhagic vessels evident under light microscopy
(data not shown). To conﬁrm the systemic endoglin-null pheno-
type as previously described, Eng-/- embryos (at E10.5) were
stained for LacZ expressed from the Eng null allele. These embryos
bore all the features previously noted, including gross defects in
vessel and heart development (Arthur et al., 2000; Bourdeau et al.,
1999; Li et al., 1999). In particular, we also noted a profound defect
in the formation of the intersomitic vasculature; the normally
ordered reticulated intersomitic vasculature was highly dis-
organized in Eng-/- embryos, suggesting defective intersomitic
vessel formation (Fig. 2B, arrows).
3.4. Endoglin targeting in Pax3-positive cells leads to intersomitic
vessel misrouting
To visualize the vascular endothelium of Pax3Cre/þ;EngLoxP/
mutant embryos and littermate controls at E10.5, we stained
embryo whole mounts with a monoclonal antibody to platelet
endothelial cell adhesion molecule-1 (PECAM-1), a vascular en-
dothelial cell marker (Baldwin et al., 1994). As compared to lit-
termate control embryos (Fig. 2C), Pax3Cre/þ;EngLoxP/ embryos
showed dilation of the intersomitic vessels, which appeared more
advanced mid-embryo (Fig. 2D, panel 3, arrow). Immuno-
ﬂuorescence staining of sections in this region for CD34, which
shows a speciﬁc endothelial cell distribution (Middleton et al.,
2005), indicated a dilated vessel structure (Fig. 2D panel 4, arrow).
To assess vascular integrity, intracardiac India ink injections
were performed as described (Krebs et al., 2010) on control and
Pax3Cre;EngLoxP/ E10.5 embryos. In control littermate embryos
(Fig. 3A), ink injected into the ventricle of the heart exited ante-
riorly through the paired branchial arch arteries, entered the
paired dorsal aortae, and traversed caudally the entire length of
the embryo. In Pax3Cre/þ;EngLoxP/ embryos (Fig. 3B), injected ink
exited through the paired branchial arch arteries, then aberrantly
entered the intersomitic vessels (Fig. 3B), consistent with mis-
routing of the vessel. Caudally, the Pax3Cre/þ;EngLoxP/ embryos
exhibited an absence of ink/blood ﬂow to caudal regions of the
embryo. Whole mount staining of embryos using anti-smooth
Fig. 1. Recombination patterns of Pax3Cre and Wnt1Cre strains. Cre recombinase mouse strains were crossed to the Rosa Cre reporter strain (Soriano, 1999). Embryos were
collected at E9.5 and E10.5, and whole mount stained for β-gal activity. Shown are E9.5 Pax3Cre/þ;Rosa embryos at the level of the optic stalk and telencephalon (A–C) and at
the level of the heart (D–F). (G–I) Wnt1Cre/þ;Rosa sections were taken from an E10.5 embryo at the level of the heart. Boxed regions in middle column are expanded as
indicated.
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Fig. 2. The Pax3Cre allele efﬁciently recombines at the endoglin locus to generate a null allele and leads to abnormal intersomitic vessel morphology. Pax3Cre/þ;Engþ/
mice were crossed with EngLoxP/LoxP homozygous mice. (A) Representative PCR was conducted on two litters from Pax3Cre/þ;Engþ / x EngLoxP/LoxP matings (M1, M2) of E10.5
embryos: Engþ /LacZ, the LacZ-targeted endoglin mutated allele; Cre, Cre recombinase transgene PCR product, the presence of which reﬂects the recombined null allele with
exons 5 and 6 are deleted. (B) Examples of control or endoglin mutant (Eng-/-) E10.5 embryos stained for Eng locus-encoded LacZ beta-galactosidase activity. Arrows indicate
Eng/LacZ expression in the control and Eng/ intersomitic vessels. (C–D) Immunohistochemical endothelial cell-speciﬁc PECAM staining of control Pax3Cre/þ;EngLoxP/þ and
mutant Pax3Cre/þ;EngLoxP/ embryos. Arrows exemplify normal and malformed intersomitic vessels. DA, dorsal aorta; cv, cardinal vein. Immunoﬂuorescence staining for
CD34þ endothelial cells is shown in the panels to the right.
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vessels (arrows, Fig. 4A, B, respectively).
3.5. Loss of endoglin in Pax3-positive cells leads to smooth muscle
cell disorganization and enhanced smooth muscle actin expression
Profound aortic vessel dilation and disorganization of vascular
smooth muscle cell layers was revealed by immunohistochemical
smooth muscle actin staining of embryonic sections. Vessels ex-
hibited larger diameters and reduced continuity between adjacent
smooth muscle cells associated with the dorsal aortae (Fig. 4C).
Potential sites of ectopic SM-actin were observed in the mutant
cardinal vein (Fig. 4D, arrows, and Fig. 7, below).
3.6. Loss of endoglin in Pax3-positive cells results in intersomitic
vessel malformation
The midsection embryonic intersomitic vasculature was further
examined using confocal microscopy. Embryos were whole mount
stained with endothelial cell-speciﬁc Griffonia lectin and thencounterstained with an antibody to pericyte-speciﬁc PDGFRβ
protein. Confocal images revealed defects in the intersomitic ves-
sels arising from the aorta (Fig. 5A). These defects presented as
dilated arches (Fig. 5B, insets in expanded views) and three di-
mensional reconstruction of the dilations indicated inappropriate
fusion and merging of the vessels (Fig. 5C).
Pax3Cre-mediated loss of endoglin expression results in vessel
dilation adjacent to the mid-embryo somites. To provide an es-
timate of the extent of anterior–posterior vessel dilation in mu-
tant embryos, serial smooth muscle actin-stained vessel sections
(as shown in Fig. 4B) were imaged throughout the embryo, the
vessel luminal areas measured, and stacked. These measure-
ments revealed variable enhanced dilations in the dorsal aortae
(Fig. 6A), and conﬁrmed that dilation was most extensive in the
sections that corresponded to the mid-embryo somites (Fig. 6B).
Similar serial section smooth muscle-stained reconstructions
revealed the presence of signiﬁcant ectopic smooth muscle actin-
staining cells positioned between the paired dorsal aortae, but
more anterior to the most dilated sections, in mutant embryos
(Fig. 7A–C). In contrast to the global Eng-targeted mouse embryo
Fig. 3. Pax3Cre-mediated endoglin recombination results in compromised inter-
somitic vessel integrity. Intracardiac India ink injections were performed on control
Pax3Cre/þ;EngLoxP/þ (A) and mutant Pax3Cre/þ;EngLoxP/ (B) E10.5 embryos. Black
arrows point to apparent misrouting of vessels corresponding to the junction of the
cardinal vein- and aorta-derived intersomitic vessels. The white arrow (A) shows
the ﬂow of injected ink caudally through the dorsal aortae in the control embryo.
Ink ﬂow caudal to the heart is absent in the Pax3Cre/þ;EngLoxP/ embryos (B).
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of smooth muscle actin-positive cells are associated with the
dorsal aorta, but appear less organized around the dilated mutant
aorta (Fig. 7B). The location of the ectopic smooth muscle actin-
staining cells was mid-level, as shown in three dimensional area
reconstruction maps of serial smooth muscle actin-stained sec-
tions (Fig. 7C), which was consistent with data shown above
(Figs. 2C and D).
To assess possible alterations in vascular smooth muscle dif-
ferentiation, cDNA was prepared from embryo thoracic sections
and used for quantitative RT-PCR (qRT-PCR). These measurements
conﬁrmed the preceding results indicating that smooth muscle
actin mRNA expression was elevated in the Pax3Cre/þ;EngLoxP/
mutant embryos (Fig. 7D). Moreover, two additional late smooth
muscle differentiation markers, smooth muscle myosin heavy
chain and smooth muscle calponin1 were also signiﬁcantly upre-
gulated. This result contrasted with expression of SM22α, which
was not signiﬁcantly altered in the mutant as compared to control
embryos (Fig. 7D).4. Discussion
Angiogenesis is a multiple step process that involves recruit-
ment of endothelial and smooth muscle cell precursors, and the
intricate orchestration of signaling events within and between
endothelial cells and vascular smooth muscle cells, which ulti-
mately invest, stabilize, and promote the maturation of developing
vessels. Pax3-positive cells mark somite-derived precursor cells
that give rise to myogenic and vascular cell fates, the latter of
which includes endothelial and vascular smooth muscle cell pre-
cursors. However, the identities of precursor cell populations and
critical genes expressed therein that contribute to vessel formation
and maturation remain to be elucidated.
The TGFβ/BMP coreceptor, endoglin, whose mutation causes
one form of the vascular disease hereditary hemorrhagic tel-
angiectasia (HHT, (McAllister et al., 1994)), is required for angio-
genesis and vascular smooth muscle cell differentiation (Arthur
et al., 2000; Bourdeau et al., 1999; Li et al., 1999), maintenance of
myogenic potential in embryonic smooth muscle precursors
(Mancini et al., 2007), and exhibits cell-autonomous roles for
vessel development in both endothelial and vascular smooth
muscle cells (Mancini et al., 2009). However, to date no conditional
targeting of endoglin designed to deﬁne its requirement in a
vascular cell precursor population during embryonic development
has been performed. Therefore, we used Wnt1- and Pax3-based
Cre recombinase-based reagents to explore the requirement for
endoglin in vascular precursor cells.
Pax3Cre, but notWnt1Cre-mediated deletion produced lethality
in mice (Table 1). Although Wnt1 and Pax3 share some expression
domains, the embryonic lineage of Pax3-expressing precursor cells
is signiﬁcantly broader by E10.5, including vascular structures. This
is consistent with loss of endoglin in Pax3-derived cells leading to
impaired vascular structure and embryonic lethality. This differ-
ence has also been observed previously. For example, systemic
knockout of connexin 43 results in cardiac outﬂow tract defects
with abnormal coronary vessel deployment. However, Wnt1Cre-
mediated deletion did not recapitulate the connexin 43-null
phenotype (Liu et al., 2006). In contrast, Pax3Cre deletion involves
both ventral and dorsal aspects of the thoracic neural tube. Using
Pax3Cre as the driver resulted in coronary anomalies similar to
those seen in connexin 43-null hearts. Because Pax3 is expressed
in rare endothelial cells and vascular smooth muscle precursors
more broadly, the lethality of the Pax3Cre;EngLoxP/ phenotype
indicated impairment of Pax3-positive precursors of both cell
types.
Fig. 4. Loss of endoglin expression in Pax3Cre-expressing cells alters smooth muscle cell development and smooth muscle actin expression. (A, B) Whole mount vascular
smooth muscle alpha actin (αSM-actin) staining of control Pax3Cre/þ;EngLoxP/þ and mutant Pax3Cre/þ;EngLoxP/ E10.5 embryos. Arrows point to (A) dilated dorsal aortae and
(B) cranial vessels. (C, D) Sections showing αSM-actin positive cells in Pax3Cre/þ;EngLoxP/þ (C) and mutant Pax3Cre/þ;EngLoxP/ (D) E10.5 embryos. Distension of the paired
aortae is apparent in the mutant, with ectopic SM-actin staining in the cardinal veins (arrows, card vein). Boxed areas are shown at higher magniﬁcation underneath.
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Fig. 5. Pax3Cre/þ;EngLoxP/ E10.5 embryos show intersomitic vessel malformation. (A) Whole mount ﬂuorescent microscopic imaging of endothelial cell( Griffonia lectin IB4,
green) and pericyte (anti-PDGFRβ, red) stained E10.5 embryos suggests profound intersomitic vessel malformation. DA, dorsal aorta. Arrows point to corresponding regions
of normal (Pax3Cre/þ;EngLoxP/þ) and abnormal (Pax3Cre/þ;EngLoxP/ ) intersomitic vessels. (B–C) Confocal microscopy (B) and three-dimensional reconstruction of the in-
tersomitic vessels (C) showing abnormal organization of the intersomitic vessels. Scale bars are: Panels B, 150 mm; Panel B insets, 100 mm; Panels C, 30 mm. (For interpretation
of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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ditional targeting of endoglin using PGK-Cre (Allinson et al., 2007)
caused a similar E9.5E10.5 lethal vascular phenotype. Our data
contrast with studies of the global endoglin-targeted E10.5 mouse
embryos, which appear to show a broader loss of vessel integrity
(Li et al., 1999). In contrast to the global endoglin null E10.5 em-
bryo, the most severe lesions appear at midlevel and smooth
muscle actin-positive vascular smooth muscle cells are present
adjacent to and investing the dorsal aorta. In addition, ectopicvascular smooth muscle cells expressing elevated levels of smooth
muscle actin are seen more distant from the aorta. Defects in in-
tersomitic vessel formation also appear most pronounced mid-
section, i.e., as a subset of the defects seen in the endoglin-tar-
geted null mouse E10.5 embryo. This phenotype could be due to
loss of endoglin expression in a subset of endothelial cells that
were derived from Pax3-positive precursors (Esner et al., 2006;
Stoller et al., 2008). This notion is supported by the observation
that dilation of dorsal aorta and intersomitic arteries was mostly
Fig. 6. Dorsal aortae of Pax3Cre/þ;EngLoxP/ E10.5 embryos are dilated. (A–B) ImageJ/FIJI morphometric analysis of serial sections of control and Pax3Cre/þ;EngLoxP/ E10.5
aortae. Serial stacked area plates exhibit loss of uniformity (A) and increased area (B) indicative of dilatation. n, horizontal bars indicate regional area differences with
po0.05.
K Young et al. / Developmental Biology 409 (2016) 95–105 103evident at the heart level but not the caudal region, such that the
defects corresponded to the region of endothelial contribution of
Pax3-positive derivatives.
As noted above, the smooth muscle actin-positive cells seen
adjacent to vessels in the Pax3Cre;EngLoxP/- mutant contrasts with
that seen in the global Eng / mutant (Arthur et al., 2000; Bour-
deau et al., 1999; Li et al., 1999; Mancini et al., 2009). This ob-
servation suggests that other cells, possibly including Pax3-nega-
tive endothelial cells populating the aortic endothelium, can
compensate for loss of endoglin in Pax3-positive precursor cells.
Because Pax3-positive precursors contribute to both endothelial
and smooth muscle constituents of the dorsal aorta, we cannot
resolve whether the observed vessel dilatation or abnormal
smooth muscle cell patterning is due to defective precursor cell
autonomous effects in vascular smooth muscle cells, or endothelial
cell-autonomous paracrine signaling defects that disrupt smooth
muscle cell migration or organization. However, as the studies to
date suggest that it is the endothelial role of endoglin that is cri-
tical for normal vessel formation (Tual-Chalot et al., 2015), it may
be the endothelial cells derived from Pax3 positive vascular pre-
cursors responsible for the critical primary defect with associated
disrupted smooth muscle organization as a secondary defect.
Further work is required to dissect the relative contributions of
Pax3 derived endoglin-deﬁcient endothelial and smooth muscle
cells to the vascular malformations.
PECAM whole mount immunostaining and intracardiac ink in-
jections demonstrated that Pax3Cre;EngLoxP/ embryos exhibited
malformation of the intersomitic vessel junctions and an absence of
blood ﬂow to caudal regions of the embryo. In a previous cardiacink injection study of Eng / null embryos, dilation of the dorsal
aortae and a similar absence of caudal blood ﬂow were observed
(Sorensen et al., 2003). However, the pattern of intersomitic vessel
malformation observed in the present study was not evident in the
prior study, suggesting that this phenotype is exacerbated in E10.5
Pax3Cre;EngLoxP/ embryos. The observed dilatation of the dorsal
aorta and the intersomitic vessels seen in the present work is
consistent with the vascular phenotype seen with Pax3-driven ex-
pression of the Notch1 intracellular domain (Mayeuf-Louchart et al.,
2014), suggesting that activated Notch signaling in Pax3-positive
precursors may suppress endoglin expression, which may con-
tribute to elevation of TGFβ signaling resulting in elevated smooth
muscle differentiation markers. Similar to our results, Notch path-
way activation in Pax3-positive progenitors can result in an increase
of the number of somatic smooth muscle and endothelial cells
contributing to the aorta (Mayeuf-Louchart et al., 2014), which is
consistent with these cells contributing to vascular smooth muscle
regulation versus a myogenic fate. Further work will be required to
evaluate this possibility.
The balance of Pax3 versus FoxC2 expression is a determinant
of the myogenic- versus vascular fate of the respective cell pre-
cursors (Lagha et al., 2009). We were unable to detect changes in
the levels of either Pax3 (adjusted for gene dosage due to the Cre
allele) or FoxC1 by qRT-PCR (data not shown). However, any such
changes in the targeted cells may have been masked by other cell
contributions. Additionally, a recent study suggests that endoglin
is regulated by Pax3 in the context of the endothelial cell and
tumor progression (Fang et al., 2013). Because we did not see
signiﬁcant lethality or vascular defects (data not shown) for the
Fig. 7. Dorsal aortae exhibit level-speciﬁc altered smooth muscle marker expression. (A) αSM-actin-stained E10.5 control and mutant (B) embryo section that exhibits
ectopic αSM-actin staining (area indicated by arrows). (B) Enlarged images showing disorganization of αSM-actin-positive cells adjacent to the dorsal aorta (Arrows).
(C) Stack diagrams showing area measurements of aortic serial images. Colors in the reconstructions are: red and blue, the surfaces of the left and right branches of the
paired dorsal aortae (da); green, the track of the dermal myotome; yellow, the otic vesicle (ov) and SMA-positive (SMAþ) cells lying between the dorsal aortae (arrows).
(D) qRT-PCR conducted on dissected embryo midsection corresponding to the region of ectopic αSM-actin expression. SMA, smooth muscle alpha actin; SMMHC, smooth
muscle myosin heavy chain; CNN1, smooth muscle speciﬁc calponin-1; SM22α, smooth muscle speciﬁc transgelin. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
K Young et al. / Developmental Biology 409 (2016) 95–105104Pax3Cre;Engþ / genotype, we do not think Pax3 haploinsufﬁ-
ciency further reducing endoglin levels was sufﬁcient to produce a
signiﬁcant phenotypic effect.
Endoglin and ALK1 are key mediators of endothelial cell-au-
tonomous BMP9-dependent angiogenic signals (David et al., 2008;
Ricard et al., 2012; Young et al., 2012). ALK1- and endoglin-de-
pendent BMP9 targets in endothelial cells include stromal-derived
factor-1 (SDF1) (Young et al., 2012) and monocyte chemoattractant
protein-1 (MCP-1/CCL2) (Young et al., 2015). Altered expression of
one or more of these factors due to endoglin deﬁciency can,
therefore, potentially alter vessel structure or integrity. For ex-
ample, the SDF1/CXCR4 is involved in coronary artery develop-
ment (Ivins et al., 2015) and MCP-1 mediates TGFβ-dependent
vascular smooth muscle cell migration (Ma et al., 2007). Thus,
evaluation of these downstream endoglin-dependent BMP9 tar-
gets in vascular cell precursors may shed light on how deletion of
endoglin may contribute to vessel fragility, malformation, and re-
duced vessel integrity and lead to new mechanistic insights into
the cellular basis underlying HHT.Acknowledgments
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